122 related articles for article (PubMed ID: 8601705)
1. Isolation of bone marrow plasma cells by negative selection with immunomagnetic beads.
Fillola G; Muller C; Bousquet R; Fontanilles AM; Laharrague P; Corberand JX
J Immunol Methods; 1996 Mar; 190(1):127-31. PubMed ID: 8601705
[TBL] [Abstract][Full Text] [Related]
2. Immunohistochemical analysis of NOTCH1 and JAGGED1 expression in multiple myeloma and monoclonal gammopathy of undetermined significance.
Skrtić A; Korać P; Krišto DR; Ajduković Stojisavljević R; Ivanković D; Dominis M
Hum Pathol; 2010 Dec; 41(12):1702-10. PubMed ID: 20800871
[TBL] [Abstract][Full Text] [Related]
3. Determination of the growth fraction in monoclonal gammopathy with the monoclonal antibody Ki-67.
Lokhorst HM; Boom SE; Terpstra W; Roholl P; Gerdes J; Bast BJ
Br J Haematol; 1988 Aug; 69(4):477-81. PubMed ID: 3044442
[TBL] [Abstract][Full Text] [Related]
4.
Bolzoni M; Ronchetti D; Storti P; Donofrio G; Marchica V; Costa F; Agnelli L; Toscani D; Vescovini R; Todoerti K; Bonomini S; Sammarelli G; Vecchi A; Guasco D; Accardi F; Palma BD; Gamberi B; Ferrari C; Neri A; Aversa F; Giuliani N
Haematologica; 2017 Apr; 102(4):773-784. PubMed ID: 28057743
[TBL] [Abstract][Full Text] [Related]
5. Risk of progression in smouldering myeloma and monoclonal gammopathies of unknown significance: comparative analysis of the evolution of monoclonal component and multiparameter flow cytometry of bone marrow plasma cells.
Pérez-Persona E; Mateo G; García-Sanz R; Mateos MV; de Las Heras N; de Coca AG; Hernández JM; Galende J; Martín-Nuñez G; Bárez A; Alonso JM; Martín A; López-Berges C; Orfao A; San Miguel JF; Vidriales MB
Br J Haematol; 2010 Jan; 148(1):110-4. PubMed ID: 19821821
[TBL] [Abstract][Full Text] [Related]
6. CD229 Expression on Bone Marrow Plasma Cells from Patients with Multiple Myeloma and Monoclonal Gammopathies of Uncertain Significance.
Carulli G; Buda G; Azzarà A; Ciancia EM; Sammuri P; Domenichini C; Guerri V; Petrini M
Acta Haematol; 2016; 135(1):11-4. PubMed ID: 26303094
[No Abstract] [Full Text] [Related]
7. [Multiple myeloma immunophenotyping: method validation].
Vergnolle I; Rieu JB; Avet-Loiseau H; Corre J; Vergez F
Ann Biol Clin (Paris); 2019 Apr; 77(2):197-217. PubMed ID: 30998199
[TBL] [Abstract][Full Text] [Related]
8. Differentiation of plasma cell infiltrates in the bone marrow. A clinicopathological study on 80 patients including immunohistochemistry and morphometry.
Thiele J; Arenz B; Klein H; Vierbuchen M; Zankovich R; Fischer R
Virchows Arch A Pathol Anat Histopathol; 1988; 412(6):553-62. PubMed ID: 3129867
[TBL] [Abstract][Full Text] [Related]
9. Monoclonal gammopathy of undetermined significance and smoldering multiple myeloma.
Kyle RA; San-Miguel JF; Mateos MV; Rajkumar SV
Hematol Oncol Clin North Am; 2014 Oct; 28(5):775-90. PubMed ID: 25212882
[TBL] [Abstract][Full Text] [Related]
10. Lack of IL-1 secretion from human myeloma cells highly purified by immunomagnetic separation.
Borset M; Helseth E; Naume B; Waage A
Br J Haematol; 1993 Nov; 85(3):446-51. PubMed ID: 8136264
[TBL] [Abstract][Full Text] [Related]
11. Monoclonal gammopathy of undetermined significance: a new proposal of workup.
Mangiacavalli S; Cocito F; Pochintesta L; Pascutto C; Ferretti V; Varettoni M; Zappasodi P; Pompa A; Landini B; Cazzola M; Corso A
Eur J Haematol; 2013 Oct; 91(4):356-60. PubMed ID: 23859528
[TBL] [Abstract][Full Text] [Related]
12. Plural light chains in a single plasma cell of a monoclonal gammopathy undetermined significance case: an ultrastructural study.
Saito N; Konishi K; Ohta S; Kondo T; Kato M; Hashino S; Takeda H; Asaka M; Ooi HK
Hum Cell; 2007 Feb; 20(1):10-4. PubMed ID: 17506772
[TBL] [Abstract][Full Text] [Related]
13. Intracytoplasmic inclusions in plasma cells: A diagnostic adjunct in monoclonal gammopathy of undetermined significance.
Gajendra S; Sharma R; Jain S; Sachdev R; Sood N
Indian J Pathol Microbiol; 2017; 60(4):618-619. PubMed ID: 29323095
[No Abstract] [Full Text] [Related]
14. Appearance of monoclonal plasma cell diseases in whole-body magnetic resonance imaging and correlation with parameters of disease activity.
Kloth JK; Hillengass J; Listl K; Kilk K; Hielscher T; Landgren O; Delorme S; Goldschmidt H; Kauczor HU; Weber MA
Int J Cancer; 2014 Nov; 135(10):2380-6. PubMed ID: 24706394
[TBL] [Abstract][Full Text] [Related]
15. Effect of tissue shipping on plasma cell isolation, viability, and RNA integrity in the context of a centralized good laboratory practice-certified tissue banking facility.
Ahmann GJ; Chng WJ; Henderson KJ; Price-Troska TL; DeGoey RW; Timm MM; Dispenzieri A; Greipp PR; Sable-Hunt A; Bergsagel L; Fonseca R
Cancer Epidemiol Biomarkers Prev; 2008 Mar; 17(3):666-73. PubMed ID: 18349285
[TBL] [Abstract][Full Text] [Related]
16. The predictive power of serum kappa/lambda ratios for discrimination between monoclonal gammopathy of undetermined significance and multiple myeloma.
Bergón E; Miravalles E; Bergón E; Miranda I; Bergón M
Clin Chem Lab Med; 2005; 43(1):32-7. PubMed ID: 15653439
[TBL] [Abstract][Full Text] [Related]
17. [Utility of 8-colours multiparameter flow cytometry immunophenotyping of plasma cells for the management of monoclonal gammopathy].
Gressier M; Chaquin M; Lhermitte L; Asnafi V; Macintyre E; Brouzes C
Ann Biol Clin (Paris); 2013; 71(3):313-23. PubMed ID: 23747669
[TBL] [Abstract][Full Text] [Related]
18. The efficiency of tumor cell purging using immunomagnetic CD34+ cell separation systems.
Roots-Weiss A; Papadimitriou C; Serve H; Hoppe B; Koenigsmann M; Reufi B; Oberberg D; Thiel E; Berdel WE
Bone Marrow Transplant; 1997 Jun; 19(12):1239-46. PubMed ID: 9208119
[TBL] [Abstract][Full Text] [Related]
19. Isolation of circulating plasma cells from blood of patients diagnosed with clonal plasma cell disorders using cell selection microfluidics.
Kamande JW; Lindell MAM; Witek MA; Voorhees PM; Soper SA
Integr Biol (Camb); 2018 Feb; 10(2):82-91. PubMed ID: 29372735
[TBL] [Abstract][Full Text] [Related]
20. Is multidrug resistance (P-glycoprotein) an intrinsic characteristic of plasma cells in patients with monoclonal gammopathy of undetermined significance, plasmacytoma, multiple myeloma and amyloidosis?
Mongkonsritragoon W; Kimlinger T; Ahmann G; Greipp PR
Leuk Lymphoma; 1998 May; 29(5-6):577-84. PubMed ID: 9643571
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
